Oral administration of liposomal bovine lactoferrin (LbLf) effectively prevents the progression of rheumatoid arthritis (RA) in mice by inhibiting tumor necrosis factor (TNF-α) production in the pancreas (37). This evidence concerns the gene LTF and rheumatoid arthritis.